This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by examining how and why social determinants differentially impact health, healthcare, and health outcomes.
Globally, about 18 million new cases of cancer are diagnosed each year1 and 450 million people (equally composed of both sexes) suffer from severe mental illnesses (SMI). A significant subgroup of patients with cancer and SMI are disadvantaged in terms of screening for distress and psycho-oncological care.
Elsevier,

Clinical Decision Support for Pharmacogenomic Precision Medicine: Foundations and Implementation, 2022, Pages 85-106

This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by bringing attention to the inequity in access to pharmacogenomic implementation efforts and how CDS can address this issues.
A Health Policy paper on the health impacts of banned pesticides in the Yaqui population in Mexico, in the context of SDGs 3, 10, and 12, highlighting recommendations for system-level solutions and policy change to current US, UN, and global laws.
This content aligns with Goal 10: Reduced Inequalities by exploring the ways in which LCCs make possible a new generation of air traveler that previously did not have access to aeromobility. It discusses how the expansion of low-cost carriers in a region of marked socioeconomic inequality unsettles the privileged origins of flying as a means of transport, complicates the mundane position of flying as a form of mobility, and brings to the surface questions of identity, class, and race among the flying public.
Racial and Ethnic discrimination effects on adolescent mental health.
Immunogenicity in each study group. Immunogenicity (anti-RBD IgG response) was measured by ELISA and reported in RLU (relative luminescence units) normalized to CR3022.
COVID-19 vaccine efficacy has been evaluated in large clinical trials and in real-world situation. Although they have proven to be very effective in the general population, little is known about their efficacy in immunocompromised patients.
Nelfinavir is an HIV protease inhibitor that has been widely prescribed as a component of highly active antiretroviral therapy, and has been reported to exert in vitro antiviral activity against SARS-CoV-2. We here assessed the effect of Nelfinavir in a SARS-CoV-2 infection model in hamsters. 
This study explores provider preferences regarding anal cancer screening indications, initiation age, tools, and referral threshold to high resolution anoscopy (HRA). Although consensus was lacking with regard to specific screening initiation age, more respondents recommended younger initiation ages for men who have sex with men (MSM) living with HIV (LWH) compared with MSM not LWH (p
 Alluvial plots denote transitions in oral HPV infection status (any genotype) over the first four study visits in a) HIV+ and b) HIV- participants who had at least 2 valid HPV tests before loss to follow up or completion of 4th visit.
HIV has been shown to increase the likelihood of oral HPV infection. In this study, we evaluated the risk of oral HPV in HIV infected patients compared with HIV-negative controls.

Pages